

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.46100520 |
| 2 | synaptic vesicle maturation (GO:0016188) | 6.09295384 |
| 3 | locomotory exploration behavior (GO:0035641) | 5.81011958 |
| 4 | vocalization behavior (GO:0071625) | 5.71564895 |
| 5 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.71188293 |
| 6 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.53693951 |
| 7 | synaptic vesicle exocytosis (GO:0016079) | 5.34398625 |
| 8 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.31019856 |
| 9 | glutamate secretion (GO:0014047) | 5.28011931 |
| 10 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.27724141 |
| 11 | neuron cell-cell adhesion (GO:0007158) | 5.18984281 |
| 12 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.17375325 |
| 13 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.02570561 |
| 14 | exploration behavior (GO:0035640) | 4.70888750 |
| 15 | neurotransmitter secretion (GO:0007269) | 4.70028631 |
| 16 | protein localization to synapse (GO:0035418) | 4.69199123 |
| 17 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.67730274 |
| 18 | regulation of synaptic vesicle transport (GO:1902803) | 4.67458791 |
| 19 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.66882711 |
| 20 | cerebellar granule cell differentiation (GO:0021707) | 4.54863400 |
| 21 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.52403187 |
| 22 | neuronal action potential propagation (GO:0019227) | 4.49673111 |
| 23 | gamma-aminobutyric acid transport (GO:0015812) | 4.48421877 |
| 24 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.43785875 |
| 25 | layer formation in cerebral cortex (GO:0021819) | 4.43308782 |
| 26 | amino acid import (GO:0043090) | 4.37349927 |
| 27 | glutamate receptor signaling pathway (GO:0007215) | 4.37236422 |
| 28 | dendritic spine morphogenesis (GO:0060997) | 4.21355611 |
| 29 | regulation of voltage-gated calcium channel activity (GO:1901385) | 4.18106239 |
| 30 | synaptic transmission, glutamatergic (GO:0035249) | 4.17615512 |
| 31 | proline transport (GO:0015824) | 4.15584619 |
| 32 | neuron recognition (GO:0008038) | 4.12767807 |
| 33 | cellular potassium ion homeostasis (GO:0030007) | 4.04843024 |
| 34 | regulation of ARF protein signal transduction (GO:0032012) | 4.00947241 |
| 35 | neurotransmitter transport (GO:0006836) | 4.00452887 |
| 36 | long-term memory (GO:0007616) | 3.95751369 |
| 37 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.95532096 |
| 38 | synaptic vesicle endocytosis (GO:0048488) | 3.95094705 |
| 39 | neuron-neuron synaptic transmission (GO:0007270) | 3.90342239 |
| 40 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.90043485 |
| 41 | postsynaptic membrane organization (GO:0001941) | 3.88732485 |
| 42 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.85682063 |
| 43 | axonal fasciculation (GO:0007413) | 3.84991014 |
| 44 | neuromuscular process controlling posture (GO:0050884) | 3.82035045 |
| 45 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.76513815 |
| 46 | regulation of synapse structural plasticity (GO:0051823) | 3.74075067 |
| 47 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.71401875 |
| 48 | positive regulation of membrane potential (GO:0045838) | 3.70382919 |
| 49 | sodium ion export (GO:0071436) | 3.69364970 |
| 50 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.69073035 |
| 51 | transmission of nerve impulse (GO:0019226) | 3.68428470 |
| 52 | regulation of synapse maturation (GO:0090128) | 3.67967638 |
| 53 | regulation of neurotransmitter levels (GO:0001505) | 3.67790447 |
| 54 | potassium ion homeostasis (GO:0055075) | 3.67089780 |
| 55 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.64850146 |
| 56 | dendritic spine organization (GO:0097061) | 3.64289308 |
| 57 | activation of protein kinase A activity (GO:0034199) | 3.57955957 |
| 58 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.57593967 |
| 59 | central nervous system myelination (GO:0022010) | 3.56683553 |
| 60 | axon ensheathment in central nervous system (GO:0032291) | 3.56683553 |
| 61 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.55202620 |
| 62 | potassium ion import (GO:0010107) | 3.55099558 |
| 63 | regulation of postsynaptic membrane potential (GO:0060078) | 3.54152538 |
| 64 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.51259774 |
| 65 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.49327912 |
| 66 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.49139817 |
| 67 | presynaptic membrane assembly (GO:0097105) | 3.48232619 |
| 68 | regulation of synaptic plasticity (GO:0048167) | 3.47896917 |
| 69 | neuromuscular synaptic transmission (GO:0007274) | 3.47734434 |
| 70 | acidic amino acid transport (GO:0015800) | 3.47223606 |
| 71 | establishment of synaptic vesicle localization (GO:0097480) | 3.45969796 |
| 72 | synaptic vesicle transport (GO:0048489) | 3.45969796 |
| 73 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.43478623 |
| 74 | regulation of neurotransmitter secretion (GO:0046928) | 3.42245602 |
| 75 | cell communication by electrical coupling (GO:0010644) | 3.41280130 |
| 76 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.41236899 |
| 77 | regulation of vesicle fusion (GO:0031338) | 3.40255477 |
| 78 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.37287641 |
| 79 | long-term synaptic potentiation (GO:0060291) | 3.37211127 |
| 80 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.37123339 |
| 81 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.35172521 |
| 82 | neurotransmitter uptake (GO:0001504) | 3.34641400 |
| 83 | response to auditory stimulus (GO:0010996) | 3.33889235 |
| 84 | neuromuscular process controlling balance (GO:0050885) | 3.31867860 |
| 85 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.31691831 |
| 86 | glycine transport (GO:0015816) | 3.29994994 |
| 87 | vesicle docking involved in exocytosis (GO:0006904) | 3.27206782 |
| 88 | cellular sodium ion homeostasis (GO:0006883) | 3.26860489 |
| 89 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.26395762 |
| 90 | regulation of dendritic spine development (GO:0060998) | 3.25236570 |
| 91 | presynaptic membrane organization (GO:0097090) | 3.25200926 |
| 92 | dendrite morphogenesis (GO:0048813) | 3.24868280 |
| 93 | positive regulation of synapse maturation (GO:0090129) | 3.19304390 |
| 94 | cell differentiation in hindbrain (GO:0021533) | 3.19223845 |
| 95 | vesicle transport along microtubule (GO:0047496) | 3.18010777 |
| 96 | regulation of neurotransmitter transport (GO:0051588) | 3.17596311 |
| 97 | intraspecies interaction between organisms (GO:0051703) | 3.16580210 |
| 98 | social behavior (GO:0035176) | 3.16580210 |
| 99 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.16159207 |
| 100 | neuronal ion channel clustering (GO:0045161) | 3.15583415 |
| 101 | auditory behavior (GO:0031223) | 3.12900949 |
| 102 | membrane depolarization during action potential (GO:0086010) | 3.11813089 |
| 103 | prepulse inhibition (GO:0060134) | 3.10771434 |
| 104 | membrane depolarization (GO:0051899) | 3.10547435 |
| 105 | membrane hyperpolarization (GO:0060081) | 3.10217553 |
| 106 | behavioral defense response (GO:0002209) | 3.09074255 |
| 107 | behavioral fear response (GO:0001662) | 3.09074255 |
| 108 | response to histamine (GO:0034776) | 3.09016372 |
| 109 | regulation of exocytosis (GO:0017157) | 3.08879169 |
| 110 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.08307507 |
| 111 | cell migration in hindbrain (GO:0021535) | 3.06660034 |
| 112 | mating behavior (GO:0007617) | 3.05733136 |
| 113 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.05254732 |
| 114 | regulation of respiratory system process (GO:0044065) | 3.04573672 |
| 115 | L-amino acid import (GO:0043092) | 3.04456530 |
| 116 | positive regulation of synaptic transmission (GO:0050806) | 3.04385663 |
| 117 | synapse assembly (GO:0007416) | 3.04371887 |
| 118 | vesicle docking (GO:0048278) | 3.04056255 |
| 119 | regulation of synaptic transmission (GO:0050804) | 3.03791480 |
| 120 | regulation of female receptivity (GO:0045924) | 3.03450787 |
| 121 | L-glutamate transport (GO:0015813) | 3.03127083 |
| 122 | learning (GO:0007612) | 3.03093801 |
| 123 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.02255683 |
| 124 | signal release (GO:0023061) | 3.02100342 |
| 125 | synaptic transmission (GO:0007268) | 3.01914055 |
| 126 | positive regulation of dendritic spine development (GO:0060999) | 3.00516674 |
| 127 | cerebellar Purkinje cell layer development (GO:0021680) | 2.99805350 |
| 128 | adult walking behavior (GO:0007628) | 2.98719901 |
| 129 | innervation (GO:0060384) | 2.97258272 |
| 130 | positive regulation of neurotransmitter transport (GO:0051590) | 2.97001790 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.51071524 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.31702081 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.15922450 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.08835888 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.07546255 |
| 6 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.85680395 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.76312029 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.76312029 |
| 9 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.71110869 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.68748717 |
| 11 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.63235364 |
| 12 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.60706874 |
| 13 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.58965897 |
| 14 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.55629126 |
| 15 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.54282061 |
| 16 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.51645514 |
| 17 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.51061297 |
| 18 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.48404630 |
| 19 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.47956648 |
| 20 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.41430457 |
| 21 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.36283953 |
| 22 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.33661287 |
| 23 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.29149517 |
| 24 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.26839201 |
| 25 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.22922523 |
| 26 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.21954411 |
| 27 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.12067709 |
| 28 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.92820012 |
| 29 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.86162055 |
| 30 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.79774014 |
| 31 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.76864075 |
| 32 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.76391907 |
| 33 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.72370983 |
| 34 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.72299694 |
| 35 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.67700081 |
| 36 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.66312864 |
| 37 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.62595099 |
| 38 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.52630671 |
| 39 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.52195781 |
| 40 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.40606239 |
| 41 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.37389347 |
| 42 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.36539128 |
| 43 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.36480762 |
| 44 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.34289221 |
| 45 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.32207290 |
| 46 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.30205559 |
| 47 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.29782126 |
| 48 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.29283192 |
| 49 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.28847864 |
| 50 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.28828412 |
| 51 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.28550961 |
| 52 | P300_19829295_ChIP-Seq_ESCs_Human | 1.28206127 |
| 53 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.26289130 |
| 54 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.25529679 |
| 55 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.25254318 |
| 56 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.23013770 |
| 57 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.21925913 |
| 58 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.21886307 |
| 59 | AR_25329375_ChIP-Seq_VCAP_Human | 1.21737164 |
| 60 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.21410825 |
| 61 | AR_19668381_ChIP-Seq_PC3_Human | 1.18767490 |
| 62 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.18414754 |
| 63 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.15094345 |
| 64 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.12637601 |
| 65 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.11677809 |
| 66 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.11604658 |
| 67 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.11252676 |
| 68 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10302921 |
| 69 | STAT3_23295773_ChIP-Seq_U87_Human | 1.09968092 |
| 70 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.09498227 |
| 71 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.09201096 |
| 72 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.08042325 |
| 73 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.07993367 |
| 74 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.07966263 |
| 75 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.07305128 |
| 76 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.07104229 |
| 77 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.06869966 |
| 78 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.05085432 |
| 79 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.04995019 |
| 80 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.04303852 |
| 81 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.03501708 |
| 82 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.02522410 |
| 83 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.01920205 |
| 84 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.00640165 |
| 85 | TCF4_23295773_ChIP-Seq_U87_Human | 1.00566651 |
| 86 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 1.00463974 |
| 87 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.99705451 |
| 88 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.99462065 |
| 89 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.98833935 |
| 90 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.97638080 |
| 91 | KDM2B_26808549_Chip-Seq_K562_Human | 0.97443049 |
| 92 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.97229987 |
| 93 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.96756597 |
| 94 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.96406067 |
| 95 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.95921338 |
| 96 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.94632361 |
| 97 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.93647730 |
| 98 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92768182 |
| 99 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.92450557 |
| 100 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.92312899 |
| 101 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.91446134 |
| 102 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.91155217 |
| 103 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.90704608 |
| 104 | VDR_22108803_ChIP-Seq_LS180_Human | 0.89838270 |
| 105 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.89480098 |
| 106 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.87327327 |
| 107 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.87323873 |
| 108 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.86312310 |
| 109 | FUS_26573619_Chip-Seq_HEK293_Human | 0.86202207 |
| 110 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.86046896 |
| 111 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.85654439 |
| 112 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.84917787 |
| 113 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84734629 |
| 114 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.84384396 |
| 115 | RXR_22108803_ChIP-Seq_LS180_Human | 0.84219122 |
| 116 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.83780340 |
| 117 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.83280384 |
| 118 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.82993531 |
| 119 | JUN_21703547_ChIP-Seq_K562_Human | 0.82879443 |
| 120 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.82303216 |
| 121 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.81852438 |
| 122 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.81797738 |
| 123 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.81797738 |
| 124 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.79934049 |
| 125 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79812129 |
| 126 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.79353305 |
| 127 | P68_20966046_ChIP-Seq_HELA_Human | 0.78813877 |
| 128 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.75475063 |
| 129 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.75167234 |
| 130 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.72701721 |
| 131 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.71845377 |
| 132 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.69175446 |
| 133 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.68283337 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.50701730 |
| 2 | MP0003880_abnormal_central_pattern | 5.56444203 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.14534667 |
| 4 | MP0009745_abnormal_behavioral_response | 3.41943140 |
| 5 | MP0004270_analgesia | 3.31982571 |
| 6 | MP0002064_seizures | 3.23682627 |
| 7 | MP0009046_muscle_twitch | 3.22924873 |
| 8 | MP0002063_abnormal_learning/memory/cond | 3.17639242 |
| 9 | MP0005423_abnormal_somatic_nervous | 3.13177304 |
| 10 | MP0001968_abnormal_touch/_nociception | 2.97249838 |
| 11 | MP0002572_abnormal_emotion/affect_behav | 2.78635384 |
| 12 | MP0002272_abnormal_nervous_system | 2.59596141 |
| 13 | MP0001486_abnormal_startle_reflex | 2.52142126 |
| 14 | MP0001501_abnormal_sleep_pattern | 2.48174551 |
| 15 | MP0002734_abnormal_mechanical_nocicepti | 2.47872414 |
| 16 | MP0001440_abnormal_grooming_behavior | 2.21059867 |
| 17 | MP0003122_maternal_imprinting | 2.12523106 |
| 18 | MP0002736_abnormal_nociception_after | 2.11274216 |
| 19 | MP0003787_abnormal_imprinting | 2.08097127 |
| 20 | MP0006276_abnormal_autonomic_nervous | 2.01696056 |
| 21 | MP0002733_abnormal_thermal_nociception | 1.99543327 |
| 22 | MP0005645_abnormal_hypothalamus_physiol | 1.98808596 |
| 23 | MP0002735_abnormal_chemical_nociception | 1.97832266 |
| 24 | MP0002067_abnormal_sensory_capabilities | 1.97134363 |
| 25 | MP0003329_amyloid_beta_deposits | 1.92380208 |
| 26 | MP0001970_abnormal_pain_threshold | 1.90303698 |
| 27 | MP0000778_abnormal_nervous_system | 1.88680348 |
| 28 | MP0005646_abnormal_pituitary_gland | 1.84858505 |
| 29 | MP0002184_abnormal_innervation | 1.81014123 |
| 30 | MP0002557_abnormal_social/conspecific_i | 1.79774121 |
| 31 | MP0004924_abnormal_behavior | 1.74543743 |
| 32 | MP0005386_behavior/neurological_phenoty | 1.74543743 |
| 33 | MP0004858_abnormal_nervous_system | 1.73383537 |
| 34 | MP0008569_lethality_at_weaning | 1.73190670 |
| 35 | MP0004811_abnormal_neuron_physiology | 1.68895912 |
| 36 | MP0002822_catalepsy | 1.67761625 |
| 37 | MP0009780_abnormal_chondrocyte_physiolo | 1.65934881 |
| 38 | MP0000955_abnormal_spinal_cord | 1.62336599 |
| 39 | MP0002909_abnormal_adrenal_gland | 1.62131551 |
| 40 | MP0004142_abnormal_muscle_tone | 1.57580666 |
| 41 | MP0001984_abnormal_olfaction | 1.53231537 |
| 42 | MP0004885_abnormal_endolymph | 1.45811909 |
| 43 | MP0002066_abnormal_motor_capabilities/c | 1.42573269 |
| 44 | MP0002882_abnormal_neuron_morphology | 1.41067717 |
| 45 | MP0001905_abnormal_dopamine_level | 1.31797274 |
| 46 | MP0001529_abnormal_vocalization | 1.29655750 |
| 47 | MP0003879_abnormal_hair_cell | 1.29219573 |
| 48 | MP0003633_abnormal_nervous_system | 1.29198449 |
| 49 | MP0001502_abnormal_circadian_rhythm | 1.18060480 |
| 50 | MP0003123_paternal_imprinting | 1.14886390 |
| 51 | MP0002152_abnormal_brain_morphology | 1.13021042 |
| 52 | MP0003631_nervous_system_phenotype | 1.10902219 |
| 53 | MP0003690_abnormal_glial_cell | 1.05629102 |
| 54 | MP0008872_abnormal_physiological_respon | 1.05135319 |
| 55 | MP0005499_abnormal_olfactory_system | 1.04811769 |
| 56 | MP0005394_taste/olfaction_phenotype | 1.04811769 |
| 57 | MP0002638_abnormal_pupillary_reflex | 1.04073312 |
| 58 | MP0000751_myopathy | 1.01656737 |
| 59 | MP0003283_abnormal_digestive_organ | 1.00232017 |
| 60 | MP0002229_neurodegeneration | 0.99240131 |
| 61 | MP0001177_atelectasis | 0.97472039 |
| 62 | MP0004145_abnormal_muscle_electrophysio | 0.94113968 |
| 63 | MP0003121_genomic_imprinting | 0.93427486 |
| 64 | MP0000569_abnormal_digit_pigmentation | 0.93067719 |
| 65 | MP0005551_abnormal_eye_electrophysiolog | 0.92578846 |
| 66 | MP0001986_abnormal_taste_sensitivity | 0.92563831 |
| 67 | MP0003634_abnormal_glial_cell | 0.92485540 |
| 68 | MP0002069_abnormal_eating/drinking_beha | 0.92315303 |
| 69 | MP0002837_dystrophic_cardiac_calcinosis | 0.90134265 |
| 70 | MP0000920_abnormal_myelination | 0.88063903 |
| 71 | MP0003632_abnormal_nervous_system | 0.86246089 |
| 72 | MP0004147_increased_porphyrin_level | 0.85961369 |
| 73 | MP0000631_abnormal_neuroendocrine_gland | 0.80857010 |
| 74 | MP0000604_amyloidosis | 0.80831870 |
| 75 | MP0003075_altered_response_to | 0.80501866 |
| 76 | MP0008874_decreased_physiological_sensi | 0.79806627 |
| 77 | MP0004742_abnormal_vestibular_system | 0.78160348 |
| 78 | MP0000013_abnormal_adipose_tissue | 0.77319461 |
| 79 | MP0002752_abnormal_somatic_nervous | 0.75903334 |
| 80 | MP0001963_abnormal_hearing_physiology | 0.75372234 |
| 81 | MP0005535_abnormal_body_temperature | 0.75259203 |
| 82 | MP0001188_hyperpigmentation | 0.74005766 |
| 83 | MP0001346_abnormal_lacrimal_gland | 0.73591610 |
| 84 | MP0004085_abnormal_heartbeat | 0.72514029 |
| 85 | MP0010386_abnormal_urinary_bladder | 0.71469696 |
| 86 | MP0008961_abnormal_basal_metabolism | 0.70339819 |
| 87 | MP0003137_abnormal_impulse_conducting | 0.67453675 |
| 88 | MP0006072_abnormal_retinal_apoptosis | 0.66876347 |
| 89 | MP0002090_abnormal_vision | 0.65940733 |
| 90 | MP0001348_abnormal_lacrimal_gland | 0.65177570 |
| 91 | MP0003172_abnormal_lysosome_physiology | 0.64049588 |
| 92 | MP0006292_abnormal_olfactory_placode | 0.63817746 |
| 93 | MP0001943_abnormal_respiration | 0.61138963 |
| 94 | MP0002102_abnormal_ear_morphology | 0.59425404 |
| 95 | MP0005167_abnormal_blood-brain_barrier | 0.58066008 |
| 96 | MP0001664_abnormal_digestion | 0.57591858 |
| 97 | MP0004130_abnormal_muscle_cell | 0.57528426 |
| 98 | MP0003861_abnormal_nervous_system | 0.57391954 |
| 99 | MP0010769_abnormal_survival | 0.55723310 |
| 100 | MP0002653_abnormal_ependyma_morphology | 0.55662080 |
| 101 | MP0008877_abnormal_DNA_methylation | 0.55608751 |
| 102 | MP0004233_abnormal_muscle_weight | 0.55262186 |
| 103 | MP0010770_preweaning_lethality | 0.55081806 |
| 104 | MP0002082_postnatal_lethality | 0.55081806 |
| 105 | MP0001485_abnormal_pinna_reflex | 0.54744040 |
| 106 | MP0005623_abnormal_meninges_morphology | 0.54374864 |
| 107 | MP0010768_mortality/aging | 0.52389348 |
| 108 | MP0000026_abnormal_inner_ear | 0.50331278 |
| 109 | MP0003938_abnormal_ear_development | 0.50059942 |
| 110 | MP0003956_abnormal_body_size | 0.49671710 |
| 111 | MP0002873_normal_phenotype | 0.47138666 |
| 112 | MP0003183_abnormal_peptide_metabolism | 0.47003826 |
| 113 | MP0002169_no_abnormal_phenotype | 0.45791018 |
| 114 | MP0000639_abnormal_adrenal_gland | 0.42364078 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.53093880 |
| 2 | Myokymia (HP:0002411) | 6.54733387 |
| 3 | Focal seizures (HP:0007359) | 5.65608515 |
| 4 | Visual hallucinations (HP:0002367) | 5.58082715 |
| 5 | Progressive cerebellar ataxia (HP:0002073) | 4.70307284 |
| 6 | Epileptic encephalopathy (HP:0200134) | 4.64799390 |
| 7 | Atonic seizures (HP:0010819) | 4.32903283 |
| 8 | Febrile seizures (HP:0002373) | 4.31152031 |
| 9 | Absence seizures (HP:0002121) | 4.20218476 |
| 10 | Supranuclear gaze palsy (HP:0000605) | 4.07658132 |
| 11 | Generalized tonic-clonic seizures (HP:0002069) | 4.00051760 |
| 12 | Dialeptic seizures (HP:0011146) | 3.77012959 |
| 13 | Action tremor (HP:0002345) | 3.74496849 |
| 14 | Annular pancreas (HP:0001734) | 3.62682541 |
| 15 | Abnormal eating behavior (HP:0100738) | 3.59070467 |
| 16 | Broad-based gait (HP:0002136) | 3.48005759 |
| 17 | Ankle clonus (HP:0011448) | 3.45764172 |
| 18 | Mutism (HP:0002300) | 3.42416974 |
| 19 | Depression (HP:0000716) | 3.33701351 |
| 20 | Tetraplegia (HP:0002445) | 3.32276947 |
| 21 | Dysmetria (HP:0001310) | 3.27885203 |
| 22 | Dysdiadochokinesis (HP:0002075) | 3.26883894 |
| 23 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.24857870 |
| 24 | Anxiety (HP:0000739) | 3.22925965 |
| 25 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.18574148 |
| 26 | Postural instability (HP:0002172) | 3.16926805 |
| 27 | Cerebral hypomyelination (HP:0006808) | 3.16747378 |
| 28 | Gaze-evoked nystagmus (HP:0000640) | 3.10532765 |
| 29 | Poor eye contact (HP:0000817) | 3.09377376 |
| 30 | Papilledema (HP:0001085) | 3.08190746 |
| 31 | Truncal ataxia (HP:0002078) | 3.04046716 |
| 32 | Polyphagia (HP:0002591) | 3.02332093 |
| 33 | Neurofibrillary tangles (HP:0002185) | 2.98432846 |
| 34 | Cerebral inclusion bodies (HP:0100314) | 2.91676458 |
| 35 | Akinesia (HP:0002304) | 2.90531862 |
| 36 | Hemiparesis (HP:0001269) | 2.86126652 |
| 37 | Hemiplegia (HP:0002301) | 2.82960614 |
| 38 | Impaired social interactions (HP:0000735) | 2.80766128 |
| 39 | Abnormal social behavior (HP:0012433) | 2.80766128 |
| 40 | Amblyopia (HP:0000646) | 2.74890701 |
| 41 | Genetic anticipation (HP:0003743) | 2.70360081 |
| 42 | Apathy (HP:0000741) | 2.68358018 |
| 43 | Megalencephaly (HP:0001355) | 2.64597796 |
| 44 | Impaired smooth pursuit (HP:0007772) | 2.62657659 |
| 45 | Abnormality of the lower motor neuron (HP:0002366) | 2.62127058 |
| 46 | Progressive inability to walk (HP:0002505) | 2.61240426 |
| 47 | Hyperventilation (HP:0002883) | 2.60773770 |
| 48 | Intention tremor (HP:0002080) | 2.60695808 |
| 49 | Bradykinesia (HP:0002067) | 2.59798086 |
| 50 | Drooling (HP:0002307) | 2.59561362 |
| 51 | Excessive salivation (HP:0003781) | 2.59561362 |
| 52 | Spastic gait (HP:0002064) | 2.57899733 |
| 53 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.56527552 |
| 54 | Agitation (HP:0000713) | 2.56472619 |
| 55 | Urinary urgency (HP:0000012) | 2.55288559 |
| 56 | Diplopia (HP:0000651) | 2.50808024 |
| 57 | Abnormality of binocular vision (HP:0011514) | 2.50808024 |
| 58 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.49797711 |
| 59 | Ventricular fibrillation (HP:0001663) | 2.48141504 |
| 60 | Scanning speech (HP:0002168) | 2.44620077 |
| 61 | Insomnia (HP:0100785) | 2.43599869 |
| 62 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.43076607 |
| 63 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.43076607 |
| 64 | Epileptiform EEG discharges (HP:0011182) | 2.41492547 |
| 65 | Status epilepticus (HP:0002133) | 2.40930607 |
| 66 | Torticollis (HP:0000473) | 2.40727550 |
| 67 | Diminished motivation (HP:0000745) | 2.39808684 |
| 68 | Fetal akinesia sequence (HP:0001989) | 2.38263259 |
| 69 | EEG with generalized epileptiform discharges (HP:0011198) | 2.35111692 |
| 70 | Abnormality of the corticospinal tract (HP:0002492) | 2.34418716 |
| 71 | Limb dystonia (HP:0002451) | 2.29018162 |
| 72 | Psychosis (HP:0000709) | 2.27631823 |
| 73 | Pheochromocytoma (HP:0002666) | 2.26744472 |
| 74 | Hypsarrhythmia (HP:0002521) | 2.23723664 |
| 75 | Lower limb muscle weakness (HP:0007340) | 2.22248803 |
| 76 | Focal dystonia (HP:0004373) | 2.21323263 |
| 77 | Generalized myoclonic seizures (HP:0002123) | 2.18871328 |
| 78 | Absent speech (HP:0001344) | 2.15965535 |
| 79 | Split foot (HP:0001839) | 2.12434014 |
| 80 | Stereotypic behavior (HP:0000733) | 2.12047067 |
| 81 | CNS hypomyelination (HP:0003429) | 2.10527388 |
| 82 | Insidious onset (HP:0003587) | 2.10508985 |
| 83 | Termporal pattern (HP:0011008) | 2.10508985 |
| 84 | Choreoathetosis (HP:0001266) | 2.07012974 |
| 85 | Spastic tetraparesis (HP:0001285) | 2.06922421 |
| 86 | Impaired vibratory sensation (HP:0002495) | 2.04234951 |
| 87 | Abnormality of saccadic eye movements (HP:0000570) | 2.04011258 |
| 88 | Neuronal loss in central nervous system (HP:0002529) | 2.03443325 |
| 89 | Aplasia involving bones of the extremities (HP:0009825) | 2.02565301 |
| 90 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.02565301 |
| 91 | Aplasia of the phalanges of the hand (HP:0009802) | 2.02565301 |
| 92 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.00661732 |
| 93 | Lower limb asymmetry (HP:0100559) | 1.99960327 |
| 94 | Delusions (HP:0000746) | 1.98697076 |
| 95 | Hypoventilation (HP:0002791) | 1.98434353 |
| 96 | Obstructive sleep apnea (HP:0002870) | 1.95954234 |
| 97 | Spinal canal stenosis (HP:0003416) | 1.95508952 |
| 98 | Craniofacial dystonia (HP:0012179) | 1.95169339 |
| 99 | Blue irides (HP:0000635) | 1.94720775 |
| 100 | Amyotrophic lateral sclerosis (HP:0007354) | 1.93694206 |
| 101 | Gait ataxia (HP:0002066) | 1.92515655 |
| 102 | Neuroendocrine neoplasm (HP:0100634) | 1.91389683 |
| 103 | Gait imbalance (HP:0002141) | 1.90785130 |
| 104 | Memory impairment (HP:0002354) | 1.88597391 |
| 105 | Postural tremor (HP:0002174) | 1.86995859 |
| 106 | Abnormal EKG (HP:0003115) | 1.86902017 |
| 107 | Rigidity (HP:0002063) | 1.86045487 |
| 108 | Specific learning disability (HP:0001328) | 1.84658008 |
| 109 | Clonus (HP:0002169) | 1.84441128 |
| 110 | Sleep apnea (HP:0010535) | 1.84372212 |
| 111 | Incomplete penetrance (HP:0003829) | 1.83498998 |
| 112 | Slow saccadic eye movements (HP:0000514) | 1.83364723 |
| 113 | Inability to walk (HP:0002540) | 1.82641623 |
| 114 | Rapidly progressive (HP:0003678) | 1.82164543 |
| 115 | Peripheral hypomyelination (HP:0007182) | 1.81143863 |
| 116 | Dysmetric saccades (HP:0000641) | 1.79733715 |
| 117 | Pointed chin (HP:0000307) | 1.79072646 |
| 118 | Abnormality of salivation (HP:0100755) | 1.78851805 |
| 119 | Lower limb amyotrophy (HP:0007210) | 1.78125533 |
| 120 | Bronchomalacia (HP:0002780) | 1.77760598 |
| 121 | Increased circulating renin level (HP:0000848) | 1.75643103 |
| 122 | Unsteady gait (HP:0002317) | 1.74911747 |
| 123 | Hand muscle atrophy (HP:0009130) | 1.73106425 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK19 | 4.84515041 |
| 2 | NTRK3 | 4.83661382 |
| 3 | EPHA4 | 3.96133433 |
| 4 | MAP3K9 | 3.76718626 |
| 5 | MARK1 | 3.05455797 |
| 6 | MAP3K4 | 3.00813425 |
| 7 | MINK1 | 2.59960249 |
| 8 | PAK6 | 2.51750425 |
| 9 | NTRK2 | 2.46479638 |
| 10 | MAP2K7 | 2.34178312 |
| 11 | MAP3K12 | 2.23635144 |
| 12 | MAP2K4 | 2.15942090 |
| 13 | KSR2 | 1.92647567 |
| 14 | DAPK2 | 1.83234021 |
| 15 | PNCK | 1.77247654 |
| 16 | PRKD3 | 1.66581410 |
| 17 | NTRK1 | 1.64563832 |
| 18 | TNIK | 1.64035407 |
| 19 | SIK2 | 1.61456591 |
| 20 | STK38 | 1.55746585 |
| 21 | KSR1 | 1.48850211 |
| 22 | CAMKK1 | 1.47507927 |
| 23 | RIPK4 | 1.46752523 |
| 24 | GRK5 | 1.45504937 |
| 25 | CDK5 | 1.45254309 |
| 26 | PLK2 | 1.38203209 |
| 27 | CASK | 1.37342087 |
| 28 | PHKG1 | 1.32323085 |
| 29 | PHKG2 | 1.32323085 |
| 30 | ARAF | 1.31501350 |
| 31 | MAPK13 | 1.30295790 |
| 32 | PRPF4B | 1.29647159 |
| 33 | LATS2 | 1.28655259 |
| 34 | FES | 1.24754779 |
| 35 | PRKCG | 1.23121109 |
| 36 | DAPK1 | 1.18482718 |
| 37 | MAP3K13 | 1.15741582 |
| 38 | UHMK1 | 1.13902592 |
| 39 | LMTK2 | 1.10533333 |
| 40 | TYRO3 | 1.04173724 |
| 41 | CAMK2A | 0.98302936 |
| 42 | MAP3K11 | 0.90833829 |
| 43 | CDK11A | 0.90568088 |
| 44 | RIPK1 | 0.90443249 |
| 45 | PAK3 | 0.85780071 |
| 46 | PRKCH | 0.85209936 |
| 47 | CAMK1 | 0.84852392 |
| 48 | CDK18 | 0.83722245 |
| 49 | CDK15 | 0.83432919 |
| 50 | CDK14 | 0.80462507 |
| 51 | SGK494 | 0.79146562 |
| 52 | SGK223 | 0.79146562 |
| 53 | STK11 | 0.79018407 |
| 54 | OXSR1 | 0.78580116 |
| 55 | ALK | 0.74465629 |
| 56 | TNK2 | 0.74383002 |
| 57 | MAP3K2 | 0.74189314 |
| 58 | CAMK4 | 0.72885822 |
| 59 | CAMK2B | 0.71130718 |
| 60 | DYRK1A | 0.70653276 |
| 61 | CSNK1G2 | 0.70350776 |
| 62 | MAPKAPK5 | 0.68024667 |
| 63 | CAMKK2 | 0.67788355 |
| 64 | RAF1 | 0.67087276 |
| 65 | TAOK1 | 0.66922540 |
| 66 | DAPK3 | 0.62902440 |
| 67 | SGK1 | 0.59003702 |
| 68 | PKN1 | 0.58854683 |
| 69 | NEK6 | 0.58342556 |
| 70 | FGFR2 | 0.58193098 |
| 71 | FGR | 0.58110771 |
| 72 | PINK1 | 0.57750061 |
| 73 | SGK2 | 0.56233826 |
| 74 | CDC42BPA | 0.54054433 |
| 75 | RET | 0.50220405 |
| 76 | MAP3K1 | 0.49723869 |
| 77 | WNK3 | 0.49190268 |
| 78 | RPS6KA3 | 0.48594154 |
| 79 | PTK2B | 0.48059168 |
| 80 | SGK3 | 0.47308185 |
| 81 | MARK2 | 0.46833960 |
| 82 | PDK1 | 0.46771654 |
| 83 | CAMK1G | 0.46728222 |
| 84 | MAPK10 | 0.46619756 |
| 85 | CAMK2D | 0.43992695 |
| 86 | CAMK2G | 0.43003078 |
| 87 | GRK7 | 0.42998463 |
| 88 | BRAF | 0.42935953 |
| 89 | PRKCZ | 0.42575284 |
| 90 | PDPK1 | 0.42442325 |
| 91 | WNK1 | 0.40013815 |
| 92 | NME1 | 0.39558548 |
| 93 | LIMK1 | 0.39114836 |
| 94 | PRKCE | 0.38767667 |
| 95 | CCNB1 | 0.37594380 |
| 96 | BRSK1 | 0.36699532 |
| 97 | TESK1 | 0.36544326 |
| 98 | FYN | 0.36348156 |
| 99 | BMPR2 | 0.35421767 |
| 100 | ROCK2 | 0.34943388 |
| 101 | FER | 0.32930602 |
| 102 | MAPK12 | 0.31575664 |
| 103 | MAP2K6 | 0.30402957 |
| 104 | PRKCA | 0.30357318 |
| 105 | MAP3K7 | 0.30013314 |
| 106 | MAPK8 | 0.29155511 |
| 107 | DYRK1B | 0.28681765 |
| 108 | PRKCB | 0.28648788 |
| 109 | DDR2 | 0.28219118 |
| 110 | MOS | 0.28103806 |
| 111 | CSNK1E | 0.28032708 |
| 112 | CSNK1G3 | 0.27616432 |
| 113 | JAK2 | 0.27427916 |
| 114 | MUSK | 0.26761612 |
| 115 | PRKG1 | 0.26339028 |
| 116 | DYRK2 | 0.24409259 |
| 117 | MAPK4 | 0.23446163 |
| 118 | SRC | 0.21499733 |
| 119 | CSNK1D | 0.20476048 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.23741345 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.42020015 |
| 3 | GABAergic synapse_Homo sapiens_hsa04727 | 3.03021271 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.76764545 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.69006620 |
| 6 | Olfactory transduction_Homo sapiens_hsa04740 | 2.66384743 |
| 7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.65473833 |
| 8 | Long-term potentiation_Homo sapiens_hsa04720 | 2.59624762 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.55306543 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.46138694 |
| 11 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.33606169 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 2.19315689 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.14339093 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 2.02021730 |
| 15 | Taste transduction_Homo sapiens_hsa04742 | 1.97250584 |
| 16 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.92428470 |
| 17 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.79783588 |
| 18 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.77084694 |
| 19 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.76900185 |
| 20 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.74696697 |
| 21 | Long-term depression_Homo sapiens_hsa04730 | 1.73960628 |
| 22 | Cocaine addiction_Homo sapiens_hsa05030 | 1.70947864 |
| 23 | Renin secretion_Homo sapiens_hsa04924 | 1.63462404 |
| 24 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.59675702 |
| 25 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.58769982 |
| 26 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.56620582 |
| 27 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.53337898 |
| 28 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.49602133 |
| 29 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.35007459 |
| 30 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.34526613 |
| 31 | Gap junction_Homo sapiens_hsa04540 | 1.32231202 |
| 32 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.25277043 |
| 33 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.24460260 |
| 34 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.24427285 |
| 35 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.21650814 |
| 36 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.17329890 |
| 37 | Axon guidance_Homo sapiens_hsa04360 | 1.15318229 |
| 38 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.13804384 |
| 39 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.13547091 |
| 40 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.13468103 |
| 41 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.10920855 |
| 42 | Melanogenesis_Homo sapiens_hsa04916 | 1.01867243 |
| 43 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.97798728 |
| 44 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.96901737 |
| 45 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.95961583 |
| 46 | Glioma_Homo sapiens_hsa05214 | 0.95909007 |
| 47 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.93350488 |
| 48 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.89413313 |
| 49 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.87292140 |
| 50 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.84809659 |
| 51 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.83148066 |
| 52 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.82224381 |
| 53 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.81966681 |
| 54 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.80464901 |
| 55 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.76461181 |
| 56 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.76205003 |
| 57 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.72785827 |
| 58 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.70787291 |
| 59 | Phototransduction_Homo sapiens_hsa04744 | 0.68158929 |
| 60 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.66819349 |
| 61 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.66592742 |
| 62 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.66473353 |
| 63 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.66188314 |
| 64 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.64807876 |
| 65 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.59317736 |
| 66 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.58882910 |
| 67 | Bile secretion_Homo sapiens_hsa04976 | 0.57917747 |
| 68 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.55664914 |
| 69 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.54526735 |
| 70 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.53997260 |
| 71 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.52982722 |
| 72 | Prion diseases_Homo sapiens_hsa05020 | 0.52569661 |
| 73 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.52001129 |
| 74 | Alcoholism_Homo sapiens_hsa05034 | 0.51782367 |
| 75 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.51345166 |
| 76 | Mineral absorption_Homo sapiens_hsa04978 | 0.51319597 |
| 77 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.49449402 |
| 78 | Alzheimers disease_Homo sapiens_hsa05010 | 0.44989720 |
| 79 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.44104522 |
| 80 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.43832846 |
| 81 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.42617312 |
| 82 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.42541161 |
| 83 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.42256878 |
| 84 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.42186089 |
| 85 | Endocytosis_Homo sapiens_hsa04144 | 0.40394229 |
| 86 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.39846176 |
| 87 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.39628764 |
| 88 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.37786749 |
| 89 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.35513255 |
| 90 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.34230740 |
| 91 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.33296291 |
| 92 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.32657621 |
| 93 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.31781841 |
| 94 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.31552798 |
| 95 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.31308651 |
| 96 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.29733583 |
| 97 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.29244491 |
| 98 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.27541263 |
| 99 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.26540021 |
| 100 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.25904947 |
| 101 | Histidine metabolism_Homo sapiens_hsa00340 | 0.24415054 |
| 102 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.23887705 |
| 103 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.23739714 |
| 104 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.23384085 |
| 105 | Circadian rhythm_Homo sapiens_hsa04710 | 0.23020642 |
| 106 | Endometrial cancer_Homo sapiens_hsa05213 | 0.22603931 |
| 107 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.21893273 |
| 108 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.19543877 |
| 109 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.18662228 |
| 110 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.17329386 |
| 111 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.16346101 |
| 112 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.15485522 |

